Bicycle Therapeutics (BCYC) News Today $7.78 -0.04 (-0.45%) As of 10:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCYC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Bicycle Therapeutics (BCYC) Expected to Announce Earnings on ThursdayOctober 23 at 4:34 AM | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Stock Price Up 5.2% - Here's WhyOctober 17, 2025 | marketbeat.com100,291 Shares in Bicycle Therapeutics PLC Sponsored ADR $BCYC Acquired by Janney Montgomery Scott LLCOctober 16, 2025 | marketbeat.comWeiss Ratings Reaffirms Sell (D-) Rating for Bicycle Therapeutics (NASDAQ:BCYC)October 16, 2025 | americanbankingnews.comBicycle Therapeutics: Looking For Their Niche, Addressing Cash BurnOctober 15, 2025 | seekingalpha.comWeiss Ratings Reiterates Sell (D-) Rating for Bicycle Therapeutics (NASDAQ:BCYC)October 14, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Trading Down 3.4% - Should You Sell?October 13, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 12, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Trading Up 10.5% - What's Next?October 10, 2025 | marketbeat.comInsider Selling: Bicycle Therapeutics (NASDAQ:BCYC) CEO Sells 2,263 Shares of StockOctober 7, 2025 | insidertrades.comInsider Selling: Bicycle Therapeutics (NASDAQ:BCYC) CEO Sells 2,263 Shares of StockOctober 6, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 3,231 SharesOctober 6, 2025 | marketbeat.comStock Traders Purchase High Volume of Bicycle Therapeutics Call Options (NASDAQ:BCYC)October 2, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Trading Up 7.8% - Here's WhySeptember 24, 2025 | marketbeat.com126,062 Shares in Bicycle Therapeutics PLC Sponsored ADR $BCYC Bought by Acadian Asset Management LLCSeptember 18, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Rating of "Moderate Buy" from BrokeragesSeptember 17, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) has caught the attention of institutional investors who hold a sizeable 45% stakeSeptember 12, 2025 | finance.yahoo.comBicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comBicycle Therapeutics Expands Board with New AppointmentsSeptember 8, 2025 | msn.comBicycle Therapeutics Strengthens Board of Directors with New AppointmentsSeptember 8, 2025 | businesswire.comAnalysts Positive on Bicycle Therapeutics (BCYC) After Q2 ResultsSeptember 8, 2025 | msn.comCaption Management LLC Cuts Stake in Bicycle Therapeutics PLC Sponsored ADR $BCYCSeptember 3, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR $BCYC Stake Increased by Armistice Capital LLCSeptember 2, 2025 | marketbeat.comDAFNA Capital Management LLC Sells 40,000 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYCSeptember 1, 2025 | marketbeat.comLong Focus Capital Management LLC Buys 750,661 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYCSeptember 1, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR $BCYC is Tybourne Capital Management HK Ltd.'s 3rd Largest PositionAugust 31, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Average Rating of "Moderate Buy" by BrokeragesAugust 25, 2025 | marketbeat.comCandriam S.C.A. Buys 117,331 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYCAugust 24, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Short Interest Down 23.5% in JulyAugust 23, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Trading 9.6% Higher - Here's WhyAugust 15, 2025 | marketbeat.comResearch Analysts Set Expectations for BCYC FY2025 EarningsAugust 15, 2025 | marketbeat.comHC Wainwright Issues Negative Estimate for BCYC EarningsAugust 15, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Analysts Are Cutting Their Estimates: Here's What You Need To KnowAugust 14, 2025 | finance.yahoo.comJMP Securities Lowers Bicycle Therapeutics (NASDAQ:BCYC) Price Target to $10.00August 13, 2025 | marketbeat.comMorgan Stanley Cuts Bicycle Therapeutics (NASDAQ:BCYC) Price Target to $13.00August 13, 2025 | marketbeat.comBicycle Therapeutics price target lowered to $10 from $22 at Citizens JMPAugust 12, 2025 | msn.comOppenheimer Cuts Bicycle Therapeutics (NASDAQ:BCYC) Price Target to $44.00August 12, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Releases Earnings Results, Misses Expectations By $0.19 EPSAugust 11, 2025 | marketbeat.comNeed To Know: The Consensus Just Cut Its Bicycle Therapeutics plc (NASDAQ:BCYC) Estimates For 2025August 10, 2025 | finance.yahoo.comBicycle (BCYC) Q2 Revenue Falls 69%August 9, 2025 | theglobeandmail.comBicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial ResultsAugust 8, 2025 | finance.yahoo.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Shares Acquired by Westfield Capital Management Co. LPAugust 6, 2025 | marketbeat.comJefferies Financial Group Inc. Takes $3.47 Million Position in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC)August 4, 2025 | marketbeat.comBicycle Therapeutics (BCYC) to Release Earnings on TuesdayJuly 29, 2025 | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 29, 2025 | marketbeat.comDenver7 Everyday Heroes honored during the annual Courage Classic Bicycle TourJuly 21, 2025 | msn.comBicycle Therapeutics (NASDAQ:BCYC) Trading 10.1% Higher - Should You Buy?July 19, 2025 | marketbeat.comDemystifying Bicycle Therapeutics: Insights From 7 Analyst ReviewsJuly 17, 2025 | benzinga.comRoyal Bank Of Canada Lowers Bicycle Therapeutics (NASDAQ:BCYC) Price Target to $25.00July 17, 2025 | marketbeat.comPrincipal Financial Group Inc. Raises Stake in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC)July 17, 2025 | marketbeat.com Get Bicycle Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCYC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCYC Media Mentions By Week BCYC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCYC News Sentiment▼0.420.63▲Average Medical News Sentiment BCYC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCYC Articles This Week▼25▲BCYC Articles Average Week Get the Latest News and Ratings for BCYC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bicycle Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Bausch Health Cos News Today Sarepta Therapeutics News Today 89BIO News Today Mesoblast News Today Ocular Therapeutix News Today ANI Pharmaceuticals News Today Vera Therapeutics News Today Cogent Biosciences News Today Stoke Therapeutics News Today Vericel News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCYC) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredTrump cannot stop this trainGallup reports that two-thirds of Americans now view socialism favorably — a shocking shift that one analyst s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
